Liposomal encapsulation of pro-NO donor drug

Coronary artery disease was reported to be the third leading cause of mortality in Singapore in 2018. Due to the prevailing problem of atherosclerosis as a result of unhealthy eating habits, inactivity and age, remedies such as percutaneous intervention through the use of stents are in place. The fo...

Full description

Saved in:
Bibliographic Details
Main Author: Koh, Cheryl Jie Yan
Other Authors: Tan Lay Poh
Format: Final Year Project
Language:English
Published: Nanyang Technological University 2020
Subjects:
Online Access:https://hdl.handle.net/10356/138654
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-138654
record_format dspace
spelling sg-ntu-dr.10356-1386542023-03-04T15:44:45Z Liposomal encapsulation of pro-NO donor drug Koh, Cheryl Jie Yan Tan Lay Poh School of Materials Science and Engineering LPTan@ntu.edu.sg Engineering::Materials::Biomaterials Coronary artery disease was reported to be the third leading cause of mortality in Singapore in 2018. Due to the prevailing problem of atherosclerosis as a result of unhealthy eating habits, inactivity and age, remedies such as percutaneous intervention through the use of stents are in place. The focus of this project is to improve on current drug-eluting stents in the market, through using a pro-nitric oxide donor drug (S-nitrosoglutathione, GSNO), which is selective in nature, and provides a myriad of benefits to the body, potentially mitigating the problem of late stent thrombosis, as well as patients’ reliance on dual anti platelet therapy. The aim is to sustain the release of nitric oxide secreted from the drug, through the slow diffusion across the lipid bilayer of liposomes. Liposomes are utilised as drug carrier due to its biocompatibility and inert nature in the physiological body, to protect the drug as well as prevent premature elimination by the body. Herein, different phospholipids will be used to fabricate both neutral charged liposomes and negatively-charged liposomes, and their size stability characterized using Dynamic Light Scattering. The encapsulation of GSNO is first tested out using passive loading, followed by active loading, where results indicated that the loading efficiency by both methods are comparable. In-vitro release study conducted using Phosphate buffered saline solution found that the drug was not fully encapsulated in the core of the liposomes, resulting in complete release of nitric oxide within a day. Nonetheless, our findings suggest that Dipalmitoylphosphatidylcholine (DSPC) was the most stable and was able to mimic the desired sustained release profile, although more work still needs to be done to further finetune the experimental procedures to yield a better result. Bachelor of Engineering (Materials Engineering) 2020-05-11T07:26:47Z 2020-05-11T07:26:47Z 2020 Final Year Project (FYP) https://hdl.handle.net/10356/138654 en MSE/19/060 application/pdf Nanyang Technological University
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Engineering::Materials::Biomaterials
spellingShingle Engineering::Materials::Biomaterials
Koh, Cheryl Jie Yan
Liposomal encapsulation of pro-NO donor drug
description Coronary artery disease was reported to be the third leading cause of mortality in Singapore in 2018. Due to the prevailing problem of atherosclerosis as a result of unhealthy eating habits, inactivity and age, remedies such as percutaneous intervention through the use of stents are in place. The focus of this project is to improve on current drug-eluting stents in the market, through using a pro-nitric oxide donor drug (S-nitrosoglutathione, GSNO), which is selective in nature, and provides a myriad of benefits to the body, potentially mitigating the problem of late stent thrombosis, as well as patients’ reliance on dual anti platelet therapy. The aim is to sustain the release of nitric oxide secreted from the drug, through the slow diffusion across the lipid bilayer of liposomes. Liposomes are utilised as drug carrier due to its biocompatibility and inert nature in the physiological body, to protect the drug as well as prevent premature elimination by the body. Herein, different phospholipids will be used to fabricate both neutral charged liposomes and negatively-charged liposomes, and their size stability characterized using Dynamic Light Scattering. The encapsulation of GSNO is first tested out using passive loading, followed by active loading, where results indicated that the loading efficiency by both methods are comparable. In-vitro release study conducted using Phosphate buffered saline solution found that the drug was not fully encapsulated in the core of the liposomes, resulting in complete release of nitric oxide within a day. Nonetheless, our findings suggest that Dipalmitoylphosphatidylcholine (DSPC) was the most stable and was able to mimic the desired sustained release profile, although more work still needs to be done to further finetune the experimental procedures to yield a better result.
author2 Tan Lay Poh
author_facet Tan Lay Poh
Koh, Cheryl Jie Yan
format Final Year Project
author Koh, Cheryl Jie Yan
author_sort Koh, Cheryl Jie Yan
title Liposomal encapsulation of pro-NO donor drug
title_short Liposomal encapsulation of pro-NO donor drug
title_full Liposomal encapsulation of pro-NO donor drug
title_fullStr Liposomal encapsulation of pro-NO donor drug
title_full_unstemmed Liposomal encapsulation of pro-NO donor drug
title_sort liposomal encapsulation of pro-no donor drug
publisher Nanyang Technological University
publishDate 2020
url https://hdl.handle.net/10356/138654
_version_ 1759857712786571264